LC 品牌信号转导、肿瘤、临床前研究试剂现货优势、折扣促销,全系列产品7折扣促销,
产品报价:询价
更新时间:2023/4/3 18:11:18
产地:美国
品牌:LC ,LC LAB
型号:LC
厂商性质: 生产型,
公司名称: 世联博研(北京)科技有限公司
王荣 : (18618101725) (18618101725)
(联系我时,请说明是在来宝网上看到的,谢谢!)

产品报价:询价
更新时间:2023/4/3 18:11:18
产地:美国
品牌:LC ,LC LAB
型号:LC
厂商性质: 生产型,
公司名称: 世联博研(北京)科技有限公司
王荣 : (18618101725) (18618101725)
(联系我时,请说明是在来宝网上看到的,谢谢!)
世联博研北京科技有限公司代理销售的LC 品牌信号转导、肿瘤、临床前研究试剂,全系列产品大折扣优惠促销,详情致电免费电话:400-650-8506
Product # Name 9CI — see Ridaforolimus, Cat. No. R-7040. A-1803 A-769662, >99% A-6880 17-AAG, >99% AB-1010 — see Masitinib, Free Base, Cat. No. M-7007. ABT-578 — see Zotarolimus, Cat. No. Z-9040. AC010220 — see Quizartinib, Free Base, Cat. No. Q-4747 . AC220 — see Quizartinib, Free Base, Cat. No. Q-4747 . A-6900 6"-O-Acetyldaidzin, >98% Acetyldinaline — see CI-994, Free Base, Cat. No. C-2606. A-3000 6"-O-Acetylgenistin, >98% A-7860 6"-O-Acetylglycitin, >98% Adeo — see (R,S)-Rolipram, Cat. No. R-2020. Adriacin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. Adriamycin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. Adriblastin — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. Adriblastina — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. A-8644 Afatinib, Free Base, >99% Afinitor — see its active ingredient, namely Everolimus, Cat. No. E-4040. AG 490 — see Tyrphostin AG 490, Cat. No. T-9142. AG 1478 — see Tyrphostin AG 1478, Cat. No. T-7310. AG-013736 — see Axitinib, Free Base, Cat. No. A-1107. Alimta — see its active ingredient, namely Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177. 17-(Allylamino)-17-Demethoxygeldanamycin — see 17-AAG, Cat. No. A-6880. 17-(Allylamino)geldanamycin — see 17-AAG, Cat. No. A-6880. Alvespimycin — see 17-DMAG, Cat. No. D-3440. AMG-706 — see Motesanib, Diphosphate Salt, Cat. No. M-2999 and Motesanib, Free Base, Cat. No. M-2900. 2'-Amino-3'-methoxyflavone — see PD 98059, Cat. No. P-4313. AMN-107 — see Nilotinib, Cat. No. N-8207. 3-Angeloyl Ingenol — see Ingenol 3-Angelate, Cat. No. I-5900. 3-Angelyl Ingenol — see Ingenol 3-Angelate, Cat. No. I-5900. Anthra(1,9-cd)pyrazol-6(2H)-one — see SP600125, Cat. No. S-7979. Anthrapyrazolone — see SP600125, Cat. No. S-7979. Antibiotic AM-2282 — see Staurosporine, Cat. No. S-9300. Antibioitic S 7481F1 — see Cyclosporin A, Cat. No. C-6000. ANX-530 — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. AP 23573 — see Ridaforolimus, Cat. No. R-7040. Armala — see Pazopanib, Free Base, Cat. No. P-6706. ARRY-142886 — see Selumetinib, Free Base, Cat. No. S-4490. ARRY-886 — see Selumetinib, Free Base, Cat. No. S-4490. A-1040 Ascomycin, >99% Ascotoxin — see Brefeldin A, Cat. No. B-8500. AT-877 — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt, Cat. No. H-2330. ATS 1287B — see Leptomycin B, Free Acid, Cat. No. L-6100. AUY922 — see NVP-AUY922, Free Base, Cat. No. N-5300. AV-951 — see Tivozanib, Free Base, Cat. No. T-6466. A-1107 Axitinib, Free Base, >99% AY-22989 — see Rapamycin, Cat. No. R-5000. AZD-0530 — see Saracatinib, Free Base, Cat. No. S-8906. AZD2171 — see Cediranib, Free Base, Cat. No. C-4300 . AZD-2281 — see Olaparib, Cat. No. O-9201. AZD6244 — see Selumetinib, Free Base, Cat. No. S-4490. B705008K112 — see Bryostatin 1, Cat. No. B-6697. Baccatin III N-benzyl-β-phenylisoserine ester — see Paclitaxel, Cat. No. P-9600. B-1080 BafilomycinA1, >95% Bay 43-9006 — see Sorafenib, p-Toluenesulfonate Salt, Cat. No. S-8502 and Sorafenib, Free Base, Cat. No. S-8599. N-Benzoyl-7-oxostaurosporine — see Stauprimide, Cat. No. S-9344. 4'-N-Benzoyl Staurosporine — see PKC412, Cat. No. P-7600. B-2422 Bexarotene, Free Acid, >99% BEZ235 — see NVP-BEZ235, Free Base, Cat. No. N-4288. BFA — see Brefeldin A, Cat. No. B-8500. BIBF1120 — see Intedanib, Free Base, Cat. No. I-9077. BIBW-2992 — see BIIB021, Free Base, Cat. No. B-7100. B-7100 BIIB021, Free Base, >99% Biovelbin — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. BIRB 796 — see Doramapimod, Free Base, Cat. No. D-2744. BMS-354825 — see Dasatinib, Free Base, Cat. No. D-3307. BMY-40481 — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. B-1408 Bortezomib, Free Base, >99% B-1709 Bosutinib, Free Base, >99% B-8500 Brefeldin A, >99% B-6697 Bryostatin 1, >99% B-3517 Bryostatin 2, >99% BSI-201 — see Iniparib, Cat. No. I-5432. Caelyx — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. C-3987 Calyculin A, >98% Campto — see its active ingredient, namely Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. Camptosar — see its active ingredient, namely Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. Camptothecin 11 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. C-1201 Canertinib, Dihydrochloride Salt, >99% Capecitabin — see Capecitabine, Cat. No. C-2799. C-2799 Capecitabine, >99% Capecitibine — see Capecitabine, Cat. No. C-2799. Capecytabine — see Capecitabine, Cat. No. C-2799. Capiibine — see Capecitabine, Cat. No. C-2799. Caprelsa — see Vandetanib, Cat. No. V-9402. Captabin — see Capecitabine, Cat. No. C-2799. Caxeta — see Capecitabine, Cat. No. C-2799. CCI-779 — see Temsirolimus, Cat. No. T-8040. C-4300 Cediranib, Free Base, >99% Celebra — see its active ingredient, namely Celecoxib, Cat. No. C-1502. Celebrex — see its active ingredient, namely Celecoxib, Cat. No. C-1502. Celecox — see Celecoxib, Cat. No. C-1502. C-1502 Celecoxib, >99% CEP-701 — see Lestaurtinib, Cat. No. L-6307. Certican — see its active ingredient, namely Everolimus, Cat. No. E-4040. cFMS Receptor Tyrosine Kinase Inhibitor — see GW2580, Free Base, Cat. No. G-5903. CGP41251 — see PKC412, Cat. No. P-7600. CGP-57148B — see Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508. CGP-79787 — see Vatalanib, Free Base, Cat. No. V-8355 and Vatalanib, Dihydrochloride Salt, Cat. No. V-8303. C-3030 Chelerythrine Chloride, >99% CHIR-258 — see Dovitinib, Free Base, Cat. No. D-3608 and Dovitinib, Lactate Salt, Cat. No. D-3699. CHIR 911 — see CHIR99021, Free Base, Cat. No. C-6556. C-6556 CHIR99021, Free Base, >99% CI-940 — see Leptomycin B, Free Acid, Cat. No. L-6100. C-2606 CI-994, Free Base, >99% CI-1033 — see Canertinib, Dihydrochloride Salt, Cat. No. C-1201. CI-1040 — see PD 184352, Free Base, Cat. No. P-8499. Ciclosporin A — see Cyclosporin A, Cat. No. C-6000. CL-1957A — see Leptomycin B, Free Acid, Cat. No. L-6100. CNF-101 — see 17-AAG, Cat. No. A-6880. CNF2024 — see BIIB021, Free Base, Cat. No. B-7100. Cocarcinogen A1 — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680. Colforsin — see Forskolin, Cat. No. F-9929. CP 127374 — see 17-AAG, Cat. No. A-6880. CP-358774 — see Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007. CP-690550 — see Tofacitinib, Free Base, Cat. No. T-1377. CPT-11 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. C-7900 Crizotinib, Free Base, >99% CsA — see Cyclosporin A, Cat. No. C-6000. CSF-1 Receptor Inhibitor — see GW2580, Free Base, Cat. No. G-5903. CT53518 — see Tandutinib, Free Base, Cat. No. T-7802. CT99021 — see CHIR99021, Free Base, Cat. No. C-6556. C-8460 CUDC-101, Free Base, >99% Cyanein — see Brefeldin A, Cat. No. B-8500. CYC202 — see Roscovitine, Cat. No. R-1234. C-8700 Cyclopamine, Free Base, 99% C-6000 Cyclosporin A, >99% Cyclosporine — see Cyclosporin A, Cat. No. C-6000. D04014 — see Enzastaurin, Free Base, Cat. No. E-4506. Dacplat — see Oxaliplatin, Cat. No. O-7111. D-2946 Daidzein, >99% D-7878 Daidzin, >99% D-3307 Dasatinib, Free Base, >99% Decumbin — see Brefeldin A, Cat. No. B-8500. Deforolimus — see Ridaforolimus, Cat. No. R-7040. 11-Deoxyjervine — see Cyclopamine, Free Base, Cat. No. C-8700. 12-Deoxyphorbol 13-Acetate — see Prostratin, Cat. No. P-4462. dFdC — see Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. dFdCyd — see Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. D-9200 (R,S)-2,3-Dihydrodaidzein, >99% 4',7-Dihydroxyisoflavone — see Daidzein, Cat. No. D-2946. 4',7-Dihydroxyisoflavone, 7-O-β-D-glucopyranoside — see Daidzin, Cat. No. D-7878. 4',7-Dihydroxy-6-methoxyisoflavone — see Glycitein, Cat. No. G-1152. 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin — see 17-DMAG, Hydrochloride Salt, Cat. No. D-3440. DJM-166 — see PX-866, Cat. No. P-7501. DJM-2-166 — see PX-866, Cat. No. P-7501. D-3440 17-DMAG, Hydrochloride Salt, >99% D-1000 Docetaxel, >99% D-2744 Doramapimod, Free Base, >99% D-3608 Dovitinib, Free Base, >99% D-3699 Dovitinib, Lactate Salt, >99% Dox — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. Doxil — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. D-4099 Doxorubicin, Free Base, >99% D-4000 Doxorubicin, Hydrochloride Salt, >99% dPAc — see Prostratin, Cat. No. P-4462. DQ-2805 — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. Elactocin — see Leptomycin B, Free Acid, Cat. No. L-6100. Elidel — see its active ingredient, namely Pimecrolimus, Cat. No. P-6040. Ellence — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000. Eloxatin — see its active ingredient, namely Oxaliplatin, Cat. No. O-7111. Eloxatine — see Oxaliplatin, Cat. No. O-7111. Elplat — see Oxaliplatin, Cat. No. O-7111. E-3866 Entinostat, Free Base, >99% E-4506 Enzastaurin, Free Base, >99% Epiadriamycin — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000. 4'-Epidoxorubicin — see Epirubicin, Hydrochloride Salt, Cat. No. E-8000. Epirubicin Ebewe — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000. E-8000 Epirubicin, Hydrochloride Salt, >99% EPO-906 — see Epothilone B, Free Base, Cat. No. E-5500. EpoB — see Epothilone B, Free Base, Cat. No. E-5500. Eposin — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. E-5500 Epothilone B, Free Base, >99% E-5880 (R,S)-Equol, >99% Eril — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt, Cat. No. H-2330. E-4997 Erlotinib, Free Base, >99% E-4007 Erlotinib, Hydrochloride Salt, >99% Etophos — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. Etopofos — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. Etopophos — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. E-4488 Etoposide, >99% Etoposide 4'-Dihydrogenphosphate — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. E-4444 Etoposide 4'-Phosphate, Free Acid, >99% Eunades — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. E-4040 Everolimus, >99% Evotropin — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622. Exelbine — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. Faridak — see Panobinostat, Free Base, Cat. No. P-3703. Farmiblastina — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. Fasudil — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt, Cat. No. H-2330. F-4660 Fasudil, Monohydrochloride Salt, >99% FHPI — see SB 202190, Free Base, Cat. No. S-1700. FI-106 — see Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. F-4633 Fingolimod, Hydrochloride Salt, >99% F-4900 FK-506, >99% FK-520 — see Ascomycin, Cat. No. A-1040. Foloxatine — see Oxaliplatin, Cat. No. O-7111. F-9929 Forskolin, >99% FR 900520 — see Ascomycin, Cat. No. A-1040. FTY720 — see Fingolimod, Hydrochloride Salt, Cat. No. F-4633. FTY-720A — see Fingolimod, Hydrochloride Salt, Cat. No. F-4633. Fujimycin — see FK-506, Cat. No. F-4900. Gamcitabine — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. GDC-0449 — see Vismodegib, Free Base, Cat. No. V-4050. G-9252 GDC-0941, Free Base, >99% G-4408 Gefitinib, Free Base, >99% G-4500 Geldanamycin, >99% Geldanomycin — see Geldanamycin, Cat. No. G-4500. G-4199 Gemcitabine, Free Base, >99% G-4177 Gemcitabine, Hydrochloride Salt, >99% Gemcitera — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. Gemsar — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. Gemzar — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. G-6055 Genistein, >99% G-5200 Genistin, >99% GLD-36 — see 17-AAG, Cat. No. A-6880. Glamox — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508. Gleevec — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508. Glivec — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508. G-1152 Glycitein, >99% G-2822 Glycitin, >99% Goe 5549 — see CI-994, Free Base, Cat. No. C-2606. Gö 5549 — see CI-994, Free Base, Cat. No. C-2606. G-6203 Gö 6976, >99% GSK-3 Inhibitor XVI — see CHIR99021, Free Base, Cat. No. C-6556. GSK 572016 — see Lapatinib, Free Base, Cat. No. L-4899. G-5903 GW2580, Free Base, >99% GW-572016 — see Lapatinib, Free Base, Cat. No. L-4899 and Lapatinib, Di-p-Toluenesulfonate Salt, Cat. No. L-4804. GW 572016X — see Lapatinib, Free Base, Cat. No. L-4899. GW-786034 — see Pazopanib, Free Base, Cat. No. P-6706. H-5239 H-89, Dihydrochloride Salt, >99% HA-1077 — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt. H-2330 HA-1077, Dihydrochloride Salt, >99% Halochondrine A — see Okadaic Acid, Free Acid, Cat. No. O-2220. Halochondrine A, Ammonium Salt — see Okadaic Acid, Ammonium Salt, Cat. No. O-6410. Halochondrine A, Potassium Salt — see Okadaic Acid, Potassium Salt, Cat. No. O-7519. Halochondrine A, Sodium Salt — see Okadaic Acid, Sodium Salt, Cat. No. O-5857. HhAntag691 — see Vismodegib, Free Base, Cat. No. V-4050. Histone Deacetylase Inhibitor I — see Entinostat, Free Base, Cat. No. E-3866. HKI-272 — see Neratinib, Free Base, Cat. No. N-6404. Hycamptamine — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622. Hycamtin — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622. 14-Hydroxydaunomycin — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. 14-Hydroxydaunorubicine — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. I-5577 Imatinib, Free Base, >99% Imatinib Mesylate — see Imatinib, Methanesulfonate Salt, Cat. No. I-5508. I-5508 Imatinib, Methanesulfonate Salt, >99% Immunomycin — see Ascomycin, Cat. No. A-1040. INCB018424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688. INCB18424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688. IND-71677 — see Iniparib, Cat. No. I-5432. I-1711 (-)-Indolactam V, >99% I-8560 Ingenol, >99% I-5900 Ingenol 3-Angelate, >99% 3-Ingenyl Angelate — see Ingenol 3-Angelate, Cat. No. I-5900. Ingenyl 3-Angelate — see Ingenol 3-Angelate, Cat. No. I-5900. I-5432 Iniparib, 99% I-9077 Intedanib, Free Base, >99% 4-Iodo-3-nitrobenzamide — see Iniparib, Cat. No. I-5432. I-6800 Ionomycin, Calcium Salt, >99% I-5700 Ionomycin, Free Acid, >99% Iressa — see its active ingredient, namely Gefitinib, Free Base, Cat. No. G-4408. I-4122 Irinotecan, Hydrochloride Salt, Trihydrate, >99% 4',7-Isoflavandiol — see Equol, Cat. No. E-5880. Jakafi — see its active ingredient, namely Ruxolitinib, Free Base, Cat. No. D-4099 and Ruxolitinib, Phosphate Salt, Cat. No. D-4000. JNK Inhibitor II — see SP600125, Cat. No. S-7979. K-2151 K252a, >99% K-9609 K252c, >99% K-252a — see K252a, Cat. No. K-2151. K-252c — see K252c, Cat. No. K-9609. KOS-953 — see 17-AAG, Cat. No. A-6880. KRN-951 — see Tivozanib, Free Base, Cat. No. T-6466. KRX-0401 — see Perifosine, Cat. No. P-6522. KT-5555 — see Lestaurtinib, Cat. No. L-6307. K-9090 KU-0063794, Free Base, >99% KU-59436 — see Olaparib, Cat. No. O-9201. KU-63794 — see KU-0063794, Free Base, Cat. No. K-9090. KW-2307 — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. KY 12420 — see Wortmannin, Cat. No. W-2990. L 683590 — see Ascomycin, Cat. No. A-1040. L-4804 Lapatinib, Di-p-Toluenesulfonate Salt, >99% L-4899 Lapatinib, Free Base, >99% Lastet — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. LBH-589 — see Panobinostat, Free Base, Cat. No. P-3703. LCP-Siro — see Rapamycin, Cat. No. R-5000. L-6100 Leptomycin B, Free Acid, >99% L-6307 Lestaurtinib, >99% LG 1069 — see Bexarotene, Free Acid, Cat. No. B-2422. LG100069 — see Bexarotene, Free Acid, Cat. No. B-2422. LGD-1069 — see Bexarotene, Free Acid, Cat. No. B-2422. Lipodox — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. LMB — see Leptomycin B, Free Acid, Cat. No. L-6100. LY-188011 — see Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177. LY-231514 — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177. L-7962 LY 294002, >99% LY-317615 — see Enzastaurin, Free Base, Cat. No. E-4506. M-6730 6"-O-Malonyldaidzin, Free Acid, >98% M-8090 6"-O-Malonylgenistin, Free Acid, >98% M-4620 6"-O-Malonylglycitin, Free Acid, >98% Mantuamycin — see Leptomycin B, Free Acid, Cat. No. L-6100. Masatinib — see Masitinib, Free Base, Cat. No. M-7007. M-7007 Masitinib, Free Base, >99% ME-3167 — see (R,S)-Rolipram, Cat. No. R-2020. MEK1/2 Inhibitor III — see PD 325901, Free Base, Cat. No. P-9688. MG-0103 — see Mocetinostat, Free Base, Cat. No. M-2433. MG-341 — see Bortezomib, Free Base, Cat. No. B-1408. MGCD0103 — see Mocetinostat, Free Base, Cat. No. M-2433. Midostaurin — see PKC412, Cat. No. P-7600. MK-0683 — see Vorinostat, Cat. No. V-8477. MK-8669 — see Ridaforolimus, Cat. No. R-7040. MK-0457 — see Tozasertib, Free Base, Cat. No. T-2304. MLN518 — see Tandutinib, Free Base, Cat. No. T-7802. M-2433 Mocetinostat, Free Base, >99% M-2999 Motesanib, Diphosphate Salt, >99% M-2900 Motesanib, Free Base, 99% MS-27-275 — see Entinostat, Free Base, Cat. No. E-3866. MS-275 — see Entinostat, Free Base, Cat. No. E-3866. MS 275-27 — see Entinostat, Free Base, Cat. No. E-3866. MTA — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177. M-5602 Mubritinib, Free Base, >99% Myocet — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. Navelbine — see its active ingredient, namely Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. NCB018424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688. NCB18424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688. Nectrolide — see Brefeldin A, Cat. No. B-8500. N-6404 Neratinib, Free Base, >99% Nexavar — see its active ingredient, namely Sorafenib, p-Toluenesulfonate Salt, Cat. No. S-8502 and Sorafenib, Free Base, Cat. No. S-8599. N-8207 Nilotinib, Free Base, >99% Nintedanib — see Intedanib, Free Base, Cat. No. I-9077. NKA17 — see Perifosine, Cat. No. P-6522. Nogitecan — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622 . 5'-Noranhydrovinblastine — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. Novaplus — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. NVB — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. N-5300 NVP-AUY922, Free Base, >99% N-4288 NVP-BEZ235, Free Base, >99% NVP-LBH-589 — see Panobinostat, Free Base, Cat. No. P-3703. O-1666 ODQ, Free Base, >98% O-6410 Okadaic Acid, Ammonium Salt, >98% O-2220 Okadaic Acid, Free Acid, >98% O-7519 Okadaic Acid, Potassium Salt, >98% O-5857 Okadaic Acid, Sodium Salt, >98% O-9201 Olaparib, >99% Onsenal — see Celecoxib, Cat. No. C-1502. OSI-774 — see Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007. O-5679 OSU-03012, Hydrochloride Salt, >99% OSU03012 — see OSU-03012, Hydrochloride Salt, Cat. No. O-5679. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one — see ODQ, Free Base, Cat. No. O-1666. Oxalato(1R,2R-cyclohexanediamine)platinum(II) — see Oxaliplatin, Cat. No. O-7111. Oxalatoplatin — see Oxaliplatin, Cat. No. O-7111. Oxalatoplatinum — see Oxaliplatin, Cat. No. O-7111. O-7111 Oxaliplatin, >99% P-9600 Paclitaxel, >99.5% P-3703 Panobinostat, Free Base, >99% Patupilone — see Epothilone B, Free Base, Cat. No. E-5500. P-6706 Pazopanib, Free Base, >99% P-4313 PD 98059, >99% PD 114720 — see Leptomycin B, Free Acid, Cat. No. L-6100. PD 123654 — see CI-994, Free Base, Cat. No. C-2606. P-3333 PD 173074, Free Base, >99% PD 183805 — see Canertinib, Dihydrochloride Salt, Cat. No. C-1201. P-8499 PD 184352, Free Base, >99% P-9688 PD 325901, Free Base, >99% PD0325901 — see PD 325901, Free Base, Cat. No. P-9688. PD 406976 — see Gö 6976, Cat. No. G-6203. PDBu — see Phorbol 12,13-Dibutyrate, Cat. No. P-4833. 4α-PDD — see 4α-Phorbol 12,13-Didecanoate, Cat. No. P-2170. P-7177 Pemetrexed, Disodium Salt, Heptahydrate, >99% PEP005 — see Ingenol 3-Angelate, Cat. No. I-5900. P-6522 Perifosine, >99% PF-02341066 — see Crizotinib, Free Base, Cat. No. C-7900. PF-1066 — see Crizotinib, Free Base, Cat. No. C-7900. PF-02341066 — see Crizotinib, Free Base, Cat. No. C-7900. PHA-290940AD — see Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877. Pharmorubicin — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000. P-1010 Phorbol, >99% P-4833 Phorbol 12,13-Dibutyrate, >99% P-2170 4α-Phorbol 12,13-Didecanoate, >99% P-1680 Phorbol 12-Myristate 13-Acetate, >99.5% P-8880 4α-Phorbol 12-Myristate 13-Acetate, >99% PI3-Kinase α Inhibitor VIII — see PIK-75, Free Base, Cat. No. P-7858 and PIK-75, Hydrochloride Salt, Cat. No. P-7050. P-7858 PIK-75, Free Base, >98% P-7050 PIK-75, Hydrochloride Salt, >98% P-9050 PIK-90, Free Base, >98% P-6040 Pimecrolimus, >99% P-7600 PKC412, >99% PLX4032 — see Vemurafenib, Free Base, Cat. No. V-2800. PMA — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680. 4α-PMA — see 4α-Phorbol 12-Myristate 13-Acetate, Cat. No. P-8880. PNU-290940AD — see Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877. P-6666 PP242, Free Base, >99% Prograf — see FK-506, Cat. No. F-4900. P-4462 Prostratin, >99% PS-341 — see Bortezomib, Free Base, Cat. No. B-1408. PTK 787 — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355. PTK/ZK — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355. P-7501 PX-866, >99% Pynasunate — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355. 1,9-Pyrazoloanthrone — see SP600125, Cat. No. S-7979. Q-4747 Quizartinib, Free Base, >99% R-115777 — see Tipifarnib, Free Base, Cat. No. T-9104. R7204 — see Vemurafenib, Free Base, Cat. No. V-2800. RAD001 — see Everolimus, Cat. No. E-4040. Ramihyphin A — see Cyclosporin A, Cat. No. C-6000. RAPA — see Rapamycin, Cat. No. R-5000. Rapamune — see Rapamycin, Cat. No. R-5000. R-5000 Rapamycin, >99% Recentin — see its active ingredient, namely Cediranib, Free Base, Cat. No. C-4300. R-6712 Resiniferatoxin, >99% R-8765 Resiniferonol 9,13,14-Orthophenylacetate, >99% RG7204 — see Vemurafenib, Free Base, Cat. No. V-2800. R-7040 Ridaforolimus, >99% Ridorubicin — see its active ingredient, namely Epirubicin, Hydrochloride Salt, Cat. No. E-8000. ROPA — see Resiniferonol 9,13,14-Orthophenylacetate, Cat. No. R-8765. Ro 09-1978 — see Capecitabine, Cat. No. C-2799. Ro 50-8231 — see Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007. RO5185426 — see Vemurafenib, Free Base, Cat. No. V-2800. Rolazar — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177. R-2020 (R,S)-Rolipram, >99% R-1234 Roscovitine, Free Base, >99% R-9630 Rottlerin RP 54780— see Oxaliplatin, Cat. No. O-7111. RP 56976— see Docetaxel, Cat. No. D-1000. RTX — see Resiniferatoxin, Cat. No. R-6712. Rubex — see its active ingredient, namely Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000. R-6600 Ruxolitinib, Free Base R-6688 Ruxolitinib, Phosphate Salt SAHA — see Vorinostat, Cat. No. V-8477. SAPK Inhibitor II — see SP600125, Cat. No. S-7979. S-8906 Saracatinib, Free Base, >99% S-1700 SB 202190, Free Base, >99% S-3400 SB 203580, Free Base, >99% S-5100 SB 225002, >99% SB 95952 — see (R,S)-Rolipram, Cat. No. R-2020. SC-58635 — see Celecoxib, Cat. No. C-1502. SDP-012 — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799. SDZ-ASM-981 — see Pimecrolimus, Cat. No. P-6040. SDZ-RAD — see Everolimus, Cat. No. E-4040. Seliciclib — see Roscovitine, Free Base, Cat. No. R-1234. S-4490 Selumetinib, Free Base, >99% S-7272 Sepantronium Bromide, 98% SILA 9268A — see Rapamycin, Cat. No. R-5000. Sirolimus — see Rapamycin, Cat. No. R-5000. SKF-104864A — see Topotecan, Hydrochloride Salt, Cat. No. T-9622. SKI-606 — see Bosutinib, Free Base, Cat. No. B-1709. SNDX-275 — see Entinostat, Free Base, Cat. No. E-3866. Solexa — see Celecoxib, Cat. No. C-1502. S-8599 Sorafenib, Free Base, >99% S-8502 Sorafenib, p-Toluenesulfonate Salt, >99% Sorafenib Tosylate — see Sorafenib, p-Toluenesulfonate Salt, Cat. No. S-8502. S-7979 SP600125, >99% Sprycel — see its active ingredient, namely Dasatinib, Free Base, Cat. No. D-3307. SR1 — see StemRegenin 1, Free Base, Cat. No. S-2440. SR-11247 — see Bexarotene, Free Acid, Cat. No. B-2422. S-9344 Stauprimide, >99% S-9300 Staurosporine, Free Base, >99% Staurosporine Aglycone — see K-252c, Cat. No. K-9609. Staurosporinone — see K-252c, Cat. No. K-9609. S-2440 StemRegenin 1, Free Base, >99% STI-571 — see Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508. SU-11248 — see Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877. Suberanilohydroxamic Acid — see Vorinostat, Cat. No. V-8477. Suberoylanilide Hydroxamic Acid — see Vorinostat, Cat. No. V-8477. S-8877 Sunitinib, Free Base, >99% Sunitinib Maleate — see Sunitinib, Malate Salt, Cat. No. S-8803. S-8803 Sunitinib, Malate Salt, >99% Sutent — see its active ingredient, namely Sunitinib, Malate Salt, Cat. No. S-8803 and Sunitinib, Free Base, Cat. No. S-8877. Synergisidin — see Brefeldin A, Cat. No. B-8500. Tacedinaline — see CI-994, Free Base, Cat. No. C-2606. Tacrolimus — see FK-506, Cat. No. F-4900. TAK-165 — see Mubritinib, Free Base, Cat. No. M-5602. T-7802 Tandutinib, Free Base, >99% Tanespimycin — see 17-AAG, Cat. No. A-6880. Tarceva — see its active ingredient, namely Erlotinib, Free Base, Cat. No. E-4997 and Erlotinib, Hydrochloride Salt, Cat. No. E-4007. Targretin — see its active ingredient, namely Bexarotene, Free Acid, Cat. No. B-2422. Targretyn — see Bexarotene, Free Acid, Cat. No. B-2422. Targrexin — see Bexarotene, Free Acid, Cat. No. B-2422. Tasigna — see its active ingredient, namely Nilotinib, Free Base, Cat. No. N-8207. Tasocitinib — see Tofacitinib, Free Base, Cat. No. T-1377. Taxol — see Paclitaxel, Cat. No. P-9600. Taxotere — see Docetaxel, Cat. No. D-1000. Telatinib — see 17-AAG, Cat. No. A-6880. T-8040 Temsirolimus, >99% 12-O-Tetradecanoylphorbol 13-Acetate — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680. 4α-12-O-Tetradecanoylphorbol 13-Acetate — see 4α-Phorbol 12-Myristate 13-Acetate, Cat. No. P-8880. T-3250 Thapsigargin, >99% Tifolar — see Pemetrexed, Disodium Salt, Heptahydrate, Cat. No. P-7177. T-5096 Tinyatoxin, >99% T-9104 Tipifarnib, Free Base, >99% T-6466 Tivozanib, Free Base, 99% TKI-258 — see Dovitinib, Free Base, Cat. No. D-3608 and Dovitinib, Lactate Salt, Cat. No. D-3699. TNX — see Tinyatoxin, Cat. No. T-5096. T-1377 Tofacitinib, Free Base, >99% Tomtovok — see its active ingredient, namely Afatinib, Free Base, Cat. No. A-8644. Toposar — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. T-9622 Topotecan, Hydrochloride Salt, >99% Topotecin — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. Torisel — see its active ingredient, namely Temsirolimus, Cat. No. T-8040. Torkinib — see PP242, Free Base, Cat. No. P-6666. Tovok — see its active ingredient, namely Afatinib, Free Base, Cat. No. A-8644. T-2304 Tozasertib, Free Base, 99% TPA — see Phorbol 12-Myristate 13-Acetate, Cat. No. P-1680. 4α-TPA — see 4α-Phorbol 12-Myristate 13-Acetate, Cat. No. P-8880. Transplatin — see Oxaliplatin, Cat. No. O-7111. 4',5,7-Trihydroxyisoflavone — see Genistein, Cat. No. G-6055. Tykerb — see its active ingredient, namely Lapatinib, Free Base, Cat. No. L-4899 and Lapatinib, Di-p-Toluenesulfonate Salt, Cat. No. L-4804. T-9142 Tyrphostin AG 490, >99% T-7310 Tyrphostin AG 1478, Free Base, >99% Tyrphostin B42 — see Tyrphostin AG 490, Cat. No. T-9142. Tyverb — see its active ingredient, namely Lapatinib, Free Base, Cat. No. L-4899 and Lapatinib, Di-p-Toluenesulfonate Salt, Cat. No. L-4804. TYX — see Tinyatoxin, Cat. No. T-5096. U-6770 U0126, >99% U-29135 — see Geldanamycin, Cat. No. G-4500. U-101440E — see Irinotecan, Hydrochloride Salt, Trihydrate, Cat. No. I-4122. V-9402 Vandetanib, Free Base, >99% Vargatef — see its active ingredient, namely Intedanib, Free Base, Cat. No. I-9077. V-8303 Vatalanib, Dihydrochloride Salt, >99% V-8355 Vatalanib, Free Base, >99% Velcade — see Bortezomib, Free Base, Cat. No. B-1408. V-2800 Vemurafenib, Free Base, >99% Vepesid — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. VER-52296 — see NVP-AUY922, Free Base, Cat. No. N-5300. V-8766 Vinorelbine, Ditartrate Salt, >99% V-8799 Vinorelbine, Free Base, >98% V-4050 Vismodegib, Free Base, >99% V-8477 Vorinostat, >99% VP-16 — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. VP-16-213 — see Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. VX6 — see Tozasertib, Free Base, Cat. No. T-2304. VX-680 — see Tozasertib, Free Base, Cat. No. T-2304. V-9366 VX-702, Free Base, >99% W-2990 Wortmannin, >99% Xabine — see Capecitabine, Cat. No. C-2799. Xalkori — see its active ingredient, namely Crizotinib, Free Base, Cat. No. C-7900. Xeloda — see its active ingredient, namely Capecitabine, Cat. No. C-2799. YM155 — see Sepantronium Bromide, Cat. No. S-7272. YM-177 — see Celecoxib, Cat. No. C-1502. Zactima — see Vandetanib, Free Base, Cat. No. V-9402. Zarnestra — see its active ingredient, namely Tipifarnib, Free Base, Cat. No. T-9104. ZD-1839 — see Gefitinib, Free Base, Cat. No. G-4408. ZD6474 — see Vandetanib, Free Base, Cat. No. V-9402. Zelboraf — see its active ingredient, namely Vemurafenib, Free Base, Cat. No. V-2800. ZK222584 — see Vatalanib, Dihydrochloride Salt, Cat. No. V-8303 and Vatalanib, Free Base, Cat. No. V-8355. ZK-62711 — see (R,S)-Rolipram, Cat. No. R-2020. Zolinza — see its active ingredient, namely Vorinostat, Cat. No. V-8477. Zortress — see its active ingredient, namely Everolimus, Cat. No. E-4040. Z-9040 Zotarolimus, >98% Zuyeyidal — see its active ingredient, namely Etoposide, Cat. No. E-4488 and Etoposide 4'-Phosphate, Free Acid, Cat. No. E-4444. Z-1066 ZSTK474, Free Base, >99%